The Tumor Suppressor Role of Zinc Finger Protein 671 ( ZNF671 ) in Multiple Tumors Based on Cancer Single-Cell Sequencing
In humans, zinc finger protein 671 ( ) is a type of transcription factor. However, the contribution of tumor heterogeneity to the functional role of remains unknown. The present study aimed to determine the functional states of in cancer single cells based on single-cell sequencing datasets (scRNA-s...
Saved in:
Published in | Frontiers in oncology Vol. 9; p. 1214 |
---|---|
Main Authors | , , , , , , , , , , , |
Format | Journal Article |
Language | English |
Published |
Switzerland
Frontiers Media S.A
08.11.2019
|
Subjects | |
Online Access | Get full text |
Cover
Loading…
Summary: | In humans, zinc finger protein 671 (
) is a type of transcription factor. However, the contribution of tumor heterogeneity to the functional role of
remains unknown. The present study aimed to determine the functional states of
in cancer single cells based on single-cell sequencing datasets (scRNA-seq). We collected cancer-related
scRNA-seq datasets and analyzed
in the datasets. We evaluated 14 functional states of
in cancers and performed
expression and function state correlation analysis. We further applied t-distributed stochastic neighbor embedding to describe the distribution of cancer cells and to explore the functional state of
in cancer subgroups. We found that
was downregulated in eight cancer-related
scRNA-seq datasets. Functional analysis identified that
might play a tumor suppressor role in cancer. The heterogeneous functional states of cell subgroups and correlation analysis showed that
played tumor suppressor roles in heterogeneous cancer cell populations. Western blot and transwell assays identified that
inhibited EMT, migration, and invasion of CNS cancers, lung cancer, melanoma, and breast carcinoma
. These results from cancer single-cell sequencing indicated that
played a tumor suppressor role in multiple tumors and may provide us with new insights into the role of
for cancer treatment. |
---|---|
Bibliography: | ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 content type line 23 Reviewed by: Fahd Al-Mulla, Genatak, Kuwait; Zi-Qi Zheng, Sun Yat-sen University Cancer Center (SYSUCC), China This article was submitted to Molecular and Cellular Oncology, a section of the journal Frontiers in Oncology These authors have contributed equally to this work Edited by: Chang Zou, Shenzhen People's Hospital, China |
ISSN: | 2234-943X 2234-943X |
DOI: | 10.3389/fonc.2019.01214 |